Hepatorenal syndrome, acute tubular necrosis, and pneumonia may increase the need for renal replacement therapy in patients with cirrhosis and acute kidney injury.

The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

Colorectal cancer is tied to an increased risk for cardiovascular mortality, especially in individuals younger than 50 years.

The US Centers for Disease Control and Prevention is facing major changes, with five senior leaders stepping down.

Dozens of research projects focused on LGBTQ health have been canceled by the US government, alarming scientists.

The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

Among women with Crohn disease and prior perianal surgery, vaginal delivery was not associated with more adverse maternal outcomes than c-section.

Fragmented sleep is associated with the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD).

HealthDay News — Lifetime excess weight and adult weight gain are associated with an increased risk for renal cell carcinoma (RCC), according to a study published online March 24 in Cancer.

Among people with IBD, conditions developed at or before age 60 years and their age of onset are important for predicting premature death.

The FDA has granted traditional approval to Keytruda (pembrolizumab) in combination with trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma.